1 | ABC008 | - | - | - | - | [1] 15 15 |
2 | ADSVF | - | - | - | - | [2] 15 15, 96 |
3 | ALEMTUZUMAB | [1] Alemtuzumab Alemtuzumab | [1] D02802
D02802
| [1] CD52 CD52 💬 | - | [17] 13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 |
4 | Alemtuzumab (Campath) | [1] Alemtuzumab Alemtuzumab | [1] D02802
D02802
| [1] CD52 CD52 💬 | - | [1] 15 15 |
5 | Anakinra | [1] Anakinra Anakinra | [1] D02934
D02934
| [2] IL1R1 IL1R1, IL1R2 💬 | [15] Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | [17] 2 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 |
6 | ARIMOCLOMOL | [1] Arimoclomol Arimoclomol | [1] D11374
D11374
| - | - | [3] 2 2, 15, 19 |
7 | Arimoclomol citrate | [1] Arimoclomol Arimoclomol | [1] D11374
D11374
| - | - | [2] 15 15, 19 |
8 | Bimagrumab | [1] Bimagrumab Bimagrumab | [1] D10620
D10620
| [2] ACVR2A ACVR2A, ACVR2B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 15 15 |
9 | BOTULINUM TOXIN TYPE A | [1] Botulinum toxin type A Botulinum toxin type A | [1] D00783
D00783
| [1] SNAP25 SNAP25 💬 | [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [10] 2 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 |
10 | BRX-345 | - | - | - | - | [2] 2 2, 15 |
11 | BYM338 | - | - | - | - | [1] 15 15 |
12 | BYM338 (Bimagrumab) | [1] Bimagrumab Bimagrumab | [1] D10620
D10620
| [2] ACVR2A ACVR2A, ACVR2B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 15 15 |
13 | BYM338/bimagrumab | [1] Bimagrumab Bimagrumab | [1] D10620
D10620
| [2] ACVR2A ACVR2A, ACVR2B 💬 | [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬 | [1] 15 15 |
14 | Calcium | [1] Calcium Calcium | - | - | - | [30] 3 3, 6, 13, 15, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 256, 265, 274, 298, 299 |
15 | Care as usual | - | - | - | - | [1] 15 15 |
16 | Creatine | [1] Creatine Creatine | - | - | - | [16] 1 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 113, 156, 201, 256 |
17 | Diagnostic Test: Beck depression inventory fast screen (Questionnaire) | - | - | - | - | [3] 3 3, 15, 256 |
18 | Diagnostic Test: Borg Scale | - | - | - | - | [3] 3 3, 15, 256 |
19 | Diagnostic Test: Brief Pain Inventory (BPI) (Questionnaire) | - | - | - | - | [3] 3 3, 15, 256 |
20 | Diagnostic Test: Fatigue Severity and Disability Scale (FSS) (Questionnaire) | - | - | - | - | [3] 3 3, 15, 256 |
21 | Diagnostic Test: German Pain Inventory (Questionnaire) | - | - | - | - | [3] 3 3, 15, 256 |
22 | Diagnostic Test: Handheld Dynamometry (HHD) | - | - | - | - | [3] 3 3, 15, 256 |
23 | Diagnostic Test: Laboratory assessment: calcium | [1] Calcium Calcium | - | - | - | [3] 3 3, 15, 256 |
24 | Diagnostic Test: Laboratory assessment: Creatine kinase | [1] Creatine Creatine | - | - | - | [3] 3 3, 15, 256 |
25 | Diagnostic Test: Laboratory assessment: magnesium | [1] Magnesium Magnesium | - | - | - | [3] 3 3, 15, 256 |
26 | Diagnostic Test: Laboratory assessment: phosphate | [1] Phosphate ion Phosphate ion | - | - | - | [3] 3 3, 15, 256 |
27 | Diagnostic Test: Laboratory assessment: Vitamin D Level | [1] Vitamin D Vitamin D | - | - | - | [3] 3 3, 15, 256 |
28 | Diagnostic Test: Muscle ultrasound | - | - | - | - | [3] 3 3, 15, 256 |
29 | Diagnostic Test: Pressure pain threshold | - | - | - | - | [4] 3 3, 15, 113, 256 |
30 | Diagnostic Test: Quick Motor Function Test | - | - | - | - | [4] 3 3, 15, 113, 256 |
31 | Diagnostic Test: R-PAct (Questionnaire) | - | - | - | - | [3] 3 3, 15, 256 |
32 | Diagnostic Test: Rotterdam Handicap Scale (RHS) (Questionnaire) | - | - | - | - | [3] 3 3, 15, 256 |
33 | Diagnostic Test: Six-minute walk test (6MWT) | - | - | - | - | [3] 3 3, 15, 256 |
34 | Diagnostic Test: Vital signs | - | - | - | - | [3] 3 3, 15, 256 |
35 | Etanercept | [1] Etanercept Etanercept | [1] D00742
D00742
| [2] LTA LTA, TNF 💬 | [67] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [16] 15 15, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285, 298 |
36 | FLEBOGAMMA 5% | - | - | - | - | [1] 15 15 |
37 | Gamma Globulin | - | - | - | - | [2] 15 15, 50 |
38 | Genetic: Blood draw for optional genetic exome sequencing | - | - | - | - | [3] 3 3, 15, 256 |
39 | Genetic: Genetic test: ACE polymorphism | - | - | - | - | [3] 3 3, 15, 256 |
40 | Genetic: Genetic test: ACTN3 polymorphism | - | - | - | - | [3] 3 3, 15, 256 |
41 | Immunoglobulins, normal human, for intravascular adm. | - | - | - | - | [2] 14 14, 15 |
42 | Magnesium | [1] Magnesium Magnesium | - | - | - | [19] 3 3, 6, 11, 13, 15, 46, 64, 70, 93, 97, 166, 225, 235, 256, 284, 291, 296, 297, 298 |
43 | NATALIZUMAB | [1] Natalizumab Natalizumab | [1] D06886
D06886
| [1] ITGA4 ITGA4 💬 | [14] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [5] 13 13, 15, 25, 46, 96 |
44 | Null | - | - | - | - | [16] 6 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 |
45 | Other: Blood-flow restricted training | - | - | - | - | [1] 15 15 |
46 | PHENYLBUTYRATE | [1] Phenylbutyric acid Phenylbutyric acid | - | - | - | [12] 2 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338 |
47 | Phenylbutyrate Oral Tablet | [1] Phenylbutyric acid Phenylbutyric acid | - | - | - | [1] 15 15 |
48 | Phosphate | [1] Phosphate ion Phosphate ion | - | - | - | [33] 2 2, 3, 6, 11, 12, 13, 15, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 |
49 | Pioglitazone | [1] Pioglitazone Pioglitazone | [2] D00945
D00945
,
D08378
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [17] 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
50 | RAAV1.CMV.huFollistatin344 | - | - | - | - | [2] 15 15, 113 |
51 | Rapamycin | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [19] 2 2, 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 193, 256, 278, 279 |
52 | REGN2477+REGN1033 | - | - | - | - | [1] 15 15 |
53 | Simvastatin | [1] Simvastatin Simvastatin | [1] D00434
D00434
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [21] 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 |
54 | Sirolimus | [1] Sirolimus Sirolimus | [1] D00753
D00753
| [1] MTOR MTOR 💬 | [51] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [36] 6 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 |
55 | SIVASTIN | - | - | - | - | [1] 15 15 |
56 | Vitamin D | [1] Vitamin D Vitamin D | - | - | - | [24] 3 3, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 |
57 | Xeomin | [1] Botulinum toxin type A Botulinum toxin type A | [1] D00783
D00783
| [1] SNAP25 SNAP25 💬 | [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [7] 5 5, 6, 7, 13, 15, 17, 113 |